glp 1 and seizures Mapping the effectiveness risks of GLP-1 receptor agonists GLP-1 and Low Blood Pressure:

How Patients May Help Reduce the Risk of Side Effects Start With Provider Evaluation Medical evaluation matters before beginning peptide therapy

Retatrutide-related nausea should not be worsened by AOD-9604

Exp Ther Med (2016) 12(5):288592

Djuzel, Viktor

When a patient is prescribed Ozempic for weight loss, it is considered an off-label prescription, which means that the prescription was written at the providers discretion using their medical expertise when determining that the medication was medically appropriate for the patients health condition, even when it was not FDA-approved for this condition

These findings suggest that the degree of weight loss is associated with the preventive effect of these adverse events and that at least 10% weight loss is likely necessary to prevent them